The main focus of the research group is in translational research in gynaecological cancers. In particular biomarker discovery and development (specifically immunological markers) in ovarian and endometrial cancers. The biomarkers are now in the process of being tested for diagnosis and surgical prognosis. The concept of predicting surgical outcome in ovarian cancer is a step in developing personalised medicine and providing patients with best care possible.
Recent advances in oncolgy have improved survival in patients with cancer but research into surgery may have additional benefits for the patient. Clinical research into optimal treatment of cervival preinvasive lesions has been a focus. We have shown that clear margins of resection has a significant effect on reducing risk of recurrence from preinvasive disease.
et al., 2021, Uterine Transplantation: Review of Livebirths and Reproductive Implications., Transplantation, Vol:105, Pages:1695-1707
Keefe D, 2021, Fertility Treatment and Cancers-The Eternal Conundrum: A Systematic Review and Meta-analysis, Obstetrical & Gynecological Survey, Vol:76, ISSN:0029-7828, Pages:343-344
et al., 2021, Anxiety and stress in women with suspected endometrial cancer: Survey and paired observational study, Psycho-oncology: Journal of the Psychological, Social and Behavioral Dimensions of Cancer, ISSN:1057-9249
et al., 2021, The application of metabolomics in ovarian cancer management: a systematic review, International Journal of Gynecological Cancer, Vol:31, ISSN:1048-891X, Pages:754-774
et al., 2021, Do delays to surgery influence survival in endometrial cancer?, WILEY, Pages:69-69, ISSN:1470-0328